Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Simin Wen, Zhengyu Wu, Shuyi Zhong, Mao Li & Yuelong Shu. (2021) Factors influencing the immunogenicity of influenza vaccines. Human Vaccines & Immunotherapeutics 17:8, pages 2706-2718.
Read now
Read now
Eun-Ju Ko & Sang-Moo Kang. (2018) Immunology and efficacy of MF59-adjuvanted vaccines. Human Vaccines & Immunotherapeutics 14:12, pages 3041-3045.
Read now
Read now
Claudia Maria Trombetta, Elena Gianchecchi & Emanuele Montomoli. (2018) Influenza vaccines: Evaluation of the safety profile. Human Vaccines & Immunotherapeutics 14:3, pages 657-670.
Read now
Read now
John S. Tregoning, Ryan F. Russell & Ekaterina Kinnear. (2018) Adjuvanted influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 550-564.
Read now
Read now
Articles from other publishers (15)
Charlotte Switzer, Chris P. Verschoor, Eleanor Pullenayegum, Pardeep Singh & Mark Loeb. (2022) Adjuvant-attenuated symptom severity of influenza infections in vaccinated children. Infectious Medicine 1:3, pages 163-170.
Crossref
Crossref
Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels & Isabel Leroux-Roels. (2022) The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Frontiers in Immunology 13.
Crossref
Crossref
Mark Loeb, Margaret L Russell, Caralyn Kelly-Stradiotto, Nola Fuller, Kevin Fonseca, David J.D. Earn, Khami Chokani, Lorne Babiuk, Binod Neupane, Pardeep Singh & Eleanor Pullenayegum. (2021) Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial. Vaccine 39:47, pages 6843-6851.
Crossref
Crossref
Tanja Becker, Husni Elbahesh, Leslie A Reperant, Guus F Rimmelzwaan & Albert D M E Osterhaus. (2021) Influenza Vaccines: Successes and Continuing Challenges. The Journal of Infectious Diseases 224:Supplement_4, pages S405-S419.
Crossref
Crossref
Giuseppe Palladino, Annette Ferrari, Nedzad Music, Ethan C. Settembre & Yingxia Wen. (2021) Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine. Vaccine 39:38, pages 5351-5357.
Crossref
Crossref
Randall Toy, M. Cole Keenum, Pallab Pradhan, Katelynn Phang, Patrick Chen, Chinwendu Chukwu, Lily Anh H. Nguyen, Jiaying Liu, Sambhav Jain, Gabrielle Kozlowski, Justin Hosten, Mehul S. Suthar & Krishnendu Roy. (2021) TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination. Journal of Controlled Release 330, pages 866-877.
Crossref
Crossref
Timo Vesikari, K. Ramsey, P. Pitisuttithum, R. Capeding, Esther Heijnen, Daphne Sawlwin, Janine Oberyé, Bin Zhang & Igor Smolenov. (2020) Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies. Vaccine 38:51, pages 8224-8231.
Crossref
Crossref
E. Y. Boravleva, A. V. Lunitsin, A. P. Kaplun, N. V. Bykova, I. V. Krasilnikov & A. S. Gambaryan. (2020) Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge. Biochemistry (Moscow) 85:5, pages 553-566.
Crossref
Crossref
Yu-Ju Lin, Chiao-Ni Wen, Ying-Ying Lin, Wen-Chi Hsieh, Chia-Chen Chang, Yi-Hsuan Chen, Chian-Hui Hsu, Yun-Jui Shih, Chang-Hsun Chen & Chi-Tai Fang. (2020) Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis. Nature Communications 11:1.
Crossref
Crossref
Manish M. Patel, William Davis, Lauren Beacham, Sarah Spencer, Angela P. Campbell, Kathryn Lafond, Melissa Rolfes, Min Z. Levine, Eduardo Azziz-Baumgartner, Mark G. Thompson & Alicia M. Fry. (2020) Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children – A systematic review and a meta-analysis. Vaccine 38:3, pages 608-619.
Crossref
Crossref
Sanjay S. Patel, Svetlana Bizjajeva, Kelly Lindert, Esther Heijnen & Janine Oberye. (2019) Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children. International Journal of Infectious Diseases 85, pages S26-S38.
Crossref
Crossref
Angela J.P. Campbell & Lisa A. Grohskopf. (2018) Updates on Influenza Vaccination in Children. Infectious Disease Clinics of North America 32:1, pages 75-89.
Crossref
Crossref
Amanda L. Wilkins, Dmitri Kazmin, Giorgio Napolitani, Elizabeth A. Clutterbuck, Bali Pulendran, Claire-Anne Siegrist & Andrew J. Pollard. (2017) AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Frontiers in Immunology 8.
Crossref
Crossref
Susanna Esposito & Nicola Principi. (2017) Clinical trial research in focus: factors that hamper the development and evaluation of influenza vaccines. The Lancet Respiratory Medicine 5:3, pages 164-166.
Crossref
Crossref
Raúl Ortiz de Lejarazu & Sonia Tamames. (2015) Vacunación antigripal. Efectividad de las vacunas actuales y retos de futuro. Enfermedades Infecciosas y Microbiología Clínica 33:7, pages 480-490.
Crossref
Crossref